Author:
Seystahl Katharina,Wick Wolfgang,Weller Michael
Reference146 articles.
1. A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma;Addeo;J. Neurooncol.,2011
2. Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas;Balmaceda;Cancer,2008
3. ‘Recurrent’ glioblastoma multiforme, when should we reoperate;Barbagallo;Br. J. Neurosurg.,2008
4. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma;Batchelor;J. Clin. Oncol.,2010
5. Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma;Batchelor;J. Clin. Oncol.,2013
Cited by
171 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献